Page last updated: 2024-08-24

nexopamil and Heart Disease, Ischemic

nexopamil has been researched along with Heart Disease, Ischemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, M; Hohlfeld, T; Schrör, K; Strobach, H1
Hutter, JJ; Nearing, BD; Verrier, RL1

Other Studies

2 other study(ies) available for nexopamil and Heart Disease, Ischemic

ArticleYear
Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:6

    Topics: Animals; Blood Platelets; Calcium Channel Blockers; Creatine Kinase; Diastole; Epoprostenol; Female; Granulocytes; Heart; Hemodynamics; Male; Methoxamine; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Serotonin Antagonists; Swine; Swine, Miniature; Thromboxane B2; Vasodilation; Verapamil

1994
Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
    Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Dogs; Electrocardiography; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Serotonin Antagonists; Verapamil

1996